Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 414.41 million compared to CNY 473.11 million a year ago. Revenue was CNY 414.41 million compared to CNY 473.11 million a year ago.

Net income was CNY 45.26 million compared to CNY 36.15 million a year ago. Basic earnings per share from continuing operations was CNY 0.14 compared to CNY 0.11 a year ago. Diluted earnings per share from continuing operations was CNY 0.14 compared to CNY 0.11 a year ago.